| Dr Edward D Rigtrup, MD, FAAP | |
|
1120 15th St, Augusta, GA 30912-0004 | |
| (706) 721-2191 | |
| Not Available |
| Full Name | Dr Edward D Rigtrup |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1120 15th St, Augusta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023182557 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 25MA03690600 (New Jersey) | Secondary |
| 208000000X | Pediatrics | 069944 (Georgia) | Primary |
| Entity Name | Au Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841230620 PECOS PAC ID: 9931013513 Enrollment ID: O20040107000188 |
News Archive
Kamada LTD., a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, was granted an Orphan Drug Designation for its Alpha-1 Antitrypsin (AAT) product to treat type 1 diabetes.
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
Advancing options for persons living with chronic back pain, UC San Diego Health has completed the first surgery in the nation to implant a device that uses neurostimulation in the form of electrical pulses to key nerves and muscles responsible for stabilizing the lower back.
According to new clinical data presented today at ACC.12 - the 61st Annual Scientific Session & Expo of the American College of Cardiology (ACC) - the Resolute drug-eluting stent (DES) from Medtronic, Inc. maintains a powerful and persistent treatment effect for a wide variety of patients with coronary artery disease, including those with diabetes mellitus, through two years of follow-up.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published an exclusive interview with the CEO of Novelos Therapeutics, Inc., Harry S. Palmin.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward D Rigtrup, MD, FAAP 1499 Walton Way, Suite 1400, Augusta, GA 30901-2602 Ph: (706) 724-6100 | Dr Edward D Rigtrup, MD, FAAP 1120 15th St, Augusta, GA 30912-0004 Ph: (706) 721-2191 |
News Archive
Kamada LTD., a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, was granted an Orphan Drug Designation for its Alpha-1 Antitrypsin (AAT) product to treat type 1 diabetes.
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
Advancing options for persons living with chronic back pain, UC San Diego Health has completed the first surgery in the nation to implant a device that uses neurostimulation in the form of electrical pulses to key nerves and muscles responsible for stabilizing the lower back.
According to new clinical data presented today at ACC.12 - the 61st Annual Scientific Session & Expo of the American College of Cardiology (ACC) - the Resolute drug-eluting stent (DES) from Medtronic, Inc. maintains a powerful and persistent treatment effect for a wide variety of patients with coronary artery disease, including those with diabetes mellitus, through two years of follow-up.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published an exclusive interview with the CEO of Novelos Therapeutics, Inc., Harry S. Palmin.
› Verified 2 days ago
Kenny Esho, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 574-850-2999 | |
Janelle Mcgill, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8623 | |
Kristen Beeler, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1446 Harper St, Augusta, GA 30912 Phone: 706-721-5437 | |
Lorna Evorie Bell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-4951 Fax: 706-721-7941 | |
Dr. William Weston Iii, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 93 Bristlecone Ct., Augusta, GA 30909 Phone: 706-736-3704 | |
Dr. Amanda Chaffin, Pediatrics Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-9442 | |
Aaron W Hanna, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1245 Augusta West Pkwy, Augusta, GA 30909 Phone: 706-868-0389 Fax: 706-651-0729 |